The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 01, 2020
Filed:
Feb. 27, 2017
Applicant:
Otsuka Pharmaceutical Co., Ltd., Tokyo, JP;
Inventors:
Yoshikazu Kawano, Osaka, JP;
Hiroshi Shimizu, Osaka, JP;
Shunpei Ishikawa, Osaka, JP;
Isao Takemura, Osaka, JP;
Norimitsu Hariguchi, Osaka, JP;
Miki Matsuba, Osaka, JP;
Makoto Matsumoto, Osaka, JP;
Assignee:
OTSUKA PHARMACEUTICAL CO., LTD., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 411/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 211/44 (2006.01); A61K 31/498 (2006.01); A61K 31/55 (2006.01); A61K 31/554 (2006.01); A61K 31/4725 (2006.01); A61K 31/517 (2006.01); A61K 31/553 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/5415 (2006.01); A61K 31/4525 (2006.01); A61K 31/4709 (2006.01); A61K 31/536 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/454 (2013.01); A61K 31/4525 (2013.01); A61K 31/4545 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/498 (2013.01); A61K 31/517 (2013.01); A61K 31/536 (2013.01); A61K 31/5415 (2013.01); A61K 31/55 (2013.01); A61K 31/553 (2013.01); A61K 31/554 (2013.01); C07D 211/44 (2013.01); C07D 405/12 (2013.01); C07D 411/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01);
Abstract
The purpose of the present invention is to provide a compound having excellent antibacterial activity against, multidrug-resistant tuberculosis bacteria, and/or non-tuberculous acid-fast bacteria. A compound represented by formula [I]: (in the formula, each symbol is as described in the attached specification), or a salt thereof can be used to diagnose, prevent, and/or treat tuberculosis.